
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $205.3M | -- | -- | -$0.07 | -- |
08/01/2025 | Q2 | $218.1M | -- | -- | -$0.09 | -- |
05/01/2025 | Q1 | $212.4M | $217.9M | -$0.26 | -$0.17 | -$0.09 |
02/27/2025 | Q4 | $207.6M | $218.2M | -$0.22 | -$0.04 | -$0.18 |
10/31/2024 | Q3 | $229.6M | $213.8M | -$0.26 | $0.08 | -$0.34 |
08/01/2024 | Q2 | $242.6M | $237.1M | $0.10 | -$0.02 | $0.12 |
05/02/2024 | Q1 | $223M | $239.2M | -$0.22 | -$0.04 | -$0.18 |
02/29/2024 | Q4 | $234.2M | $229.5M | $0.11 | $0.10 | $0.01 |
11/02/2023 | Q3 | -- | -- | $0.08 | $0.02 | $0.06 |
08/03/2023 | Q2 | -- | -- | -$0.11 | -$0.11 | -- |
05/04/2023 | Q1 | -- | -- | -$0.27 | -$0.30 | $0.03 |
03/02/2023 | Q4 | -- | -- | -- | $0.18 | -- |
11/03/2022 | Q3 | -- | -- | $0.03 | -$0.03 | $0.06 |
08/04/2022 | Q2 | -- | -- | -$0.27 | -$0.22 | -$0.06 |
05/05/2022 | Q1 | -- | -- | -$0.28 | -$0.34 | $0.06 |
03/01/2022 | Q4 | -- | -- | -$0.23 | -$0.25 | $0.02 |
10/28/2021 | Q3 | -- | -- | -$0.38 | -$0.30 | -$0.08 |
08/05/2021 | Q2 | -- | -- | $0.72 | -- | -- |
04/29/2021 | Q1 | -- | -- | $0.00 | -$0.03 | $0.04 |
02/25/2021 | Q4 | -- | -- | $0.14 | $0.03 | $0.11 |
10/29/2020 | Q3 | -- | -- | $0.25 | -$0.15 | $0.40 |
07/30/2020 | Q2 | -- | -- | -$0.81 | -$0.66 | -$0.15 |
05/07/2020 | Q1 | -- | -- | $0.13 | $0.18 | -$0.05 |
02/27/2020 | Q4 | -- | -- | $0.16 | $0.35 | -$0.19 |
10/31/2019 | Q3 | -- | -- | $0.24 | $0.37 | -$0.13 |
08/01/2019 | Q2 | -- | -- | $0.36 | $0.26 | $0.10 |
05/02/2019 | Q1 | -- | -- | $0.44 | $0.35 | $0.09 |
02/28/2019 | Q4 | -- | -- | $0.50 | $0.42 | $0.08 |
10/29/2018 | Q3 | -- | -- | $0.47 | $0.44 | $0.03 |
08/02/2018 | Q2 | -- | -- | $0.55 | $0.53 | $0.02 |
05/03/2018 | Q1 | -- | -- | $0.47 | $0.48 | -$0.01 |
03/01/2018 | Q4 | -- | -- | $0.42 | $0.39 | $0.03 |
11/02/2017 | Q3 | -- | -- | $0.36 | $0.32 | $0.04 |
08/03/2017 | Q2 | -- | -- | $0.42 | $0.32 | $0.10 |
05/04/2017 | Q1 | -- | -- | $0.33 | $0.33 | -$0.01 |
03/02/2017 | Q4 | -- | -- | $0.34 | $0.29 | $0.05 |
10/27/2016 | Q3 | -- | -- | $0.36 | $0.35 | $0.01 |
08/02/2016 | Q2 | -- | -- | $0.41 | $0.31 | $0.10 |
05/04/2016 | Q1 | -- | -- | $0.31 | $0.25 | $0.06 |
03/01/2016 | Q4 | -- | -- | $0.25 | $0.22 | $0.03 |
11/03/2015 | Q3 | -- | -- | $0.27 | $0.23 | $0.04 |
Stoneridge reported $217.9M worth of top line sales in its most recent quarter.
Stoneridge announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.17 per share.
Stoneridge reported $46.3M that represents $1.67 per share over the last quarter.
Stoneridge's earnings are forecast to decrease from -$0.60 per share to -$0.34 per share next year representing a decrease of -46.67%.
Stoneridge's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.